171 related articles for article (PubMed ID: 33773173)
1. A drug delivery system based on nanocomposites constructed from metal-organic frameworks and Mn
Samiei Foroushani M; Zahmatkeshan A; Arkaban H; Karimi Shervedani R; Kefayat A
Colloids Surf B Biointerfaces; 2021 Jun; 202():111712. PubMed ID: 33773173
[TBL] [Abstract][Full Text] [Related]
2. A theranostic system based on nanocomposites of manganese oxide nanoparticles and a pH sensitive polymer: Preparation, and physicochemical characterization.
Samiei Foroushani M; Niroumand N; Karimi Shervedani R; Yaghoobi F; Kefayat A; Torabi M
Bioelectrochemistry; 2019 Dec; 130():107347. PubMed ID: 31437809
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
[TBL] [Abstract][Full Text] [Related]
4. A protein-sulfosalicylic acid/boswellic acids @metal-organic framework nanocomposite as anticancer drug delivery system.
Özsoy M; Atiroğlu V; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
Colloids Surf B Biointerfaces; 2021 Aug; 204():111788. PubMed ID: 33932885
[TBL] [Abstract][Full Text] [Related]
5. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
[TBL] [Abstract][Full Text] [Related]
6. MTX-Loaded Dual Thermoresponsive and pH-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer.
Najafipour A; Gharieh A; Fassihi A; Sadeghi-Aliabadi H; Mahdavian AR
Mol Pharm; 2021 Jan; 18(1):275-284. PubMed ID: 33300343
[TBL] [Abstract][Full Text] [Related]
7. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
[TBL] [Abstract][Full Text] [Related]
8. A green approach for preparation of polyacrylic acid/starch incorporated with titanium dioxide nanocomposite as a biocompatible platform for curcumin delivery to breast cancer cells.
Pourmadadi M; Tajiki A; Abdouss M
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124785. PubMed ID: 37169052
[TBL] [Abstract][Full Text] [Related]
9. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
[TBL] [Abstract][Full Text] [Related]
10. Block copolymer@ZIF-8 nanocomposites as a pH-responsive multi-steps release system for controlled drug delivery.
Lei Z; Tang Q; Ju Y; Lin Y; Bai X; Luo H; Tong Z
J Biomater Sci Polym Ed; 2020 Apr; 31(6):695-711. PubMed ID: 31914358
[TBL] [Abstract][Full Text] [Related]
11. Green synthesis of chitosan/polyacrylic acid/graphitic carbon nitride nanocarrier as a potential pH-sensitive system for curcumin delivery to MCF-7 breast cancer cells.
Abdouss H; Pourmadadi M; Zahedi P; Abdouss M; Yazdian F; Rahdar A; Díez-Pascual AM
Int J Biol Macromol; 2023 Jul; 242(Pt 3):125134. PubMed ID: 37257532
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of a theranostic system based on graphene/manganese chelate.
Karimi Shervedani R; Samiei Foroushani M; Kefayat A; Torabi M; Rahnemaye Rahsepar F
Biosens Bioelectron; 2018 Oct; 117():794-801. PubMed ID: 30096733
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of New Antibacterial Cubane-based Nanocomposite and its Application in Combination Cancer Therapy.
Zakerzadeh E; Salehi R; Mahkam M
Anticancer Agents Med Chem; 2018 Feb; 17(14):1898-1914. PubMed ID: 28530541
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells.
Abd Al-Jabbar S; Atiroğlu V; Hameed RM; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
Bioorg Chem; 2022 Jan; 118():105467. PubMed ID: 34781115
[TBL] [Abstract][Full Text] [Related]
15. Magnetically controlled drug delivery and hyperthermia effects of core-shell Cu@Mn
Mohammad F; Bwatanglang IB; Al-Lohedan HA; Shaik JP; Moosavi M; Dahan WM; Al-Tilasi HH; Aldhayan DM; Chavali M; Soleiman AA
Int J Biol Macromol; 2023 Sep; 249():126071. PubMed ID: 37524291
[TBL] [Abstract][Full Text] [Related]
16. pH- and thermo-sensitive MTX-loaded magnetic nanocomposites: synthesis, characterization, and in vitro studies on A549 lung cancer cell and MR imaging.
Farshbaf M; Salehi R; Annabi N; Khalilov R; Akbarzadeh A; Davaran S
Drug Dev Ind Pharm; 2018 Mar; 44(3):452-462. PubMed ID: 29098882
[TBL] [Abstract][Full Text] [Related]
17. Novel Methotrexate-Ciprofloxacin Loaded Alginate-Clay Based Nanocomposite as Anticancer and Antibacterial Co-Drug Delivery System.
Mahkam M; Bazmi Zeynabad F; Alizadeh E; Rahimi M; Rahimi F; Salehi R
Adv Pharm Bull; 2021 May; 11(3):477-489. PubMed ID: 34513622
[No Abstract] [Full Text] [Related]
18. Synthesis of Zeolitic imidazolate frameworks-8@ layered double hydroxide polyhedral nanocomposite with designed porous voids as an effective carrier for anti-cancer drug-controlled delivery.
Dilmaghani A; Hosseini K; Tarhriz V; Yousefi V
IET Nanobiotechnol; 2023 Jun; 17(4):326-336. PubMed ID: 37021433
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of poly(ethylene glycol)-coated mesoporous nanocomposite ZnO@Fe
Alavi AS; Meshkini A
Eur J Pharm Sci; 2018 Mar; 115():144-157. PubMed ID: 29353012
[TBL] [Abstract][Full Text] [Related]
20. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
